378 related articles for article (PubMed ID: 22614167)
1. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.
Sekiuchi M; Kudo A; Nakabayashi K; Kanai-Azuma M; Akimoto Y; Kawakami H; Yamada A
Clin Exp Nephrol; 2012 Dec; 16(6):863-74. PubMed ID: 22614167
[TBL] [Abstract][Full Text] [Related]
2. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.
Urushihara M; Kagami S; Kuhara T; Tamaki T; Kuroda Y
Nephrol Dial Transplant; 2002 Jul; 17(7):1189-96. PubMed ID: 12105240
[TBL] [Abstract][Full Text] [Related]
3. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
Sanders JS; van Goor H; Hanemaaijer R; Kallenberg CG; Stegeman CA
Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
[TBL] [Abstract][Full Text] [Related]
4. [Expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in IgA nephropathy].
Wang J; Chen X; Shi S; Zhang Y; Tian Y
Zhonghua Nei Ke Za Zhi; 2002 Feb; 41(2):75-8. PubMed ID: 11940298
[TBL] [Abstract][Full Text] [Related]
5. Glomerular expression of matrix metalloproteinases in systemic lupus erythematosus in association with activity index and renal function.
Adamidis KN; Kopaka ME; Petraki C; Charitaki E; Apostolou T; Christodoulidou C; Nikolopoulou N; Giatromanolaki A; Vargemesis V; Passadakis P
Ren Fail; 2019 Nov; 41(1):229-237. PubMed ID: 30973283
[TBL] [Abstract][Full Text] [Related]
6. Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis.
Akiyama K; Shikata K; Sugimoto H; Matsuda M; Shikata Y; Fujimoto N; Obata K; Matsui H; Makino H
Res Commun Mol Pathol Pharmacol; 1997 Feb; 95(2):115-28. PubMed ID: 9090749
[TBL] [Abstract][Full Text] [Related]
7. Differential glomerular immunoexpression of matrix metalloproteinases MMP-2 and MMP-9 in idiopathic IgA nephropathy and Schoenlein-Henoch nephritis.
Danilewicz M; Wagrowska-Danilewicz M
Folia Histochem Cytobiol; 2010 Jan; 48(1):63-7. PubMed ID: 20529817
[TBL] [Abstract][Full Text] [Related]
8. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
9. Expression of types I, II, and III TGF-beta receptors in human glomerulonephritis.
Yamamoto T; Watanabe T; Ikegaya N; Fujigaki Y; Matsui K; Masaoka H; Nagase M; Hishida A
J Am Soc Nephrol; 1998 Dec; 9(12):2253-61. PubMed ID: 9848779
[TBL] [Abstract][Full Text] [Related]
10. Glomerular expression of matrix metalloproteinases in AL-amyloidosis and association with renal function at the time of kidney biopsy.
Charitaki E; Kastritis E; Petraki C; Liapis K; Adamidis K; Apostolou T; Christodoulidou C; Nikolopoulou N; Terpos E; Nakopoulou L; Dimopoulos MA
Clin Nephrol; 2016 Jan; 85(1):44-54. PubMed ID: 26587779
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in the peripheral blood of patients with various glomerular diseases and their implication in pathogenetic lesions: study based on an enzyme-linked assay and immunohistochemical staining.
Endo T; Nakabayashi K; Sekiuchi M; Kuroda T; Soejima A; Yamada A
Clin Exp Nephrol; 2006 Dec; 10(4):253-61. PubMed ID: 17186329
[TBL] [Abstract][Full Text] [Related]
12. Expression of nephrin in acquired human glomerular disease.
Huh W; Kim DJ; Kim MK; Kim YG; Oh HY; Ruotsalainen V; Tryggvason K
Nephrol Dial Transplant; 2002 Mar; 17(3):478-84. PubMed ID: 11865096
[TBL] [Abstract][Full Text] [Related]
13. Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney.
Abe K; Miyazaki M; Koji T; Furusu A; Ozono Y; Harada T; Sakai H; Nakane PK; Kohno S
Kidney Int; 1998 Jul; 54(1):120-30. PubMed ID: 9648070
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.
Miyake-Ogawa C; Miyazaki M; Abe K; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
Am J Nephrol; 2005; 25(1):1-12. PubMed ID: 15644622
[TBL] [Abstract][Full Text] [Related]
15. Decrease in cell proliferation by an matrix metalloproteinase inhibitor, doxycycline, in a model of immune-complex nephritis.
Saglam F; Celik A; Tayfur D; Cavdar Z; Yilmaz O; Sarioglu S; Kolatan E; Oktay G; Camsari T
Nephrology (Carlton); 2010 Aug; 15(5):560-7. PubMed ID: 20649877
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
Ulrich D; Hrynyschyn K; Pallua N
Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study on the extracellular matrix components in various renal diseases].
Chiba N
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):925-38. PubMed ID: 1770626
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue.
Brehmer B; Biesterfeld S; Jakse G
Prostate Cancer Prostatic Dis; 2003; 6(3):217-22. PubMed ID: 12970724
[TBL] [Abstract][Full Text] [Related]
20. Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q:a single-center retrospective study.
Wu L; Liu D; Xia M; Chen G; Liu Y; Zhu X; Liu H
BMC Nephrol; 2021 Jan; 22(1):43. PubMed ID: 33514328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
